BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2018068)

  • 21. Frequency of the fragile X syndrome in Japanese mentally retarded males.
    Arinami T; Kondo I; Nakajima S
    Hum Genet; 1986 Aug; 73(4):309-12. PubMed ID: 3744362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of the fragile-X syndrome in mentally retarded boys in a Swedish county.
    Gustavson KH; Blomquist HK; Holmgren G
    Am J Med Genet; 1986; 23(1-2):581-7. PubMed ID: 3953668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for the fragile X syndrome among mentally retarded males by hair root analysis.
    Tunçbilek E; Alikasifoğlu M; Aktas D; Duman F; Yanik H; Anar B; Oostra B; Willemsen R
    Am J Med Genet; 2000 Nov; 95(2):105-7. PubMed ID: 11078558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fragile X syndrome among children with mental retardation.
    Elango R; Verma IC
    Indian J Pediatr; 1996; 63(4):533-8. PubMed ID: 10832474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Martin-Bell syndrome segregating in a large kindred with normal transmitting males: clinical, cytogenetic, and linkage study.
    Johnson VP; Carpenter NJ; Skorey PA
    Am J Med Genet; 1991; 38(2-3):275-82. PubMed ID: 1673299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The strength of association between fragile (X) chromosome presence and mental retardation.
    Silverman W; Lubin R; Jenkins EC; Brown WT
    Clin Genet; 1983 Jun; 23(6):436-40. PubMed ID: 6684008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthropometric and craniofacial patterns in mentally retarded males with emphasis on the fragile X syndrome.
    Butler MG; Pratesi R; Watson MS; Breg WR; Singh DN
    Clin Genet; 1993 Sep; 44(3):129-38. PubMed ID: 8275570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of X inactivation on fragile X frequency and mental retardation.
    Rosenberg C; Vianna-Morgante AM; Otto PA; Navajas L
    Am J Med Genet; 1991; 38(2-3):421-4. PubMed ID: 2018084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population incidence and segregation ratios in the Martin-Bell syndrome.
    Webb TP; Bundey SE; Thake AI; Todd J
    Am J Med Genet; 1986; 23(1-2):573-80. PubMed ID: 3953667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetic screening in cytogenetically normal mentally retarded males with manifestations of fragile X syndrome.
    Butler MG; Pratesi R; Vnencak-Jones CL
    Am J Med Genet; 1994 Jul; 51(4):315-6. PubMed ID: 7942993
    [No Abstract]   [Full Text] [Related]  

  • 31. Dermatoglyphic findings in patients with fragile X-chromosome.
    Hirth L; Singh S; Schilling S; Müller E; Goedde HW
    Clin Genet; 1985 Feb; 27(2):118-21. PubMed ID: 3978845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of testicular volume as a clinical marker for cytogenetic disorders in mentally retarded males.
    Kirkilionis AJ; Pozsonyi J; Sergovich FR
    J Ment Defic Res; 1988 Feb; 32 ( Pt 1)():19-30. PubMed ID: 2896248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragile X chromosome in institutionalized male adults with mental retardation.
    Aoi T; Takashima H; Takada T; Okada T
    Keio J Med; 1989 Mar; 38(1):36-9. PubMed ID: 2785613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular diagnosis of fragile X syndrome].
    Ben Jemaa L; Khemir S; Maazoul F; Richard L; Beldjord C; Chaabouni M; Chaabouni H
    Tunis Med; 2008 Nov; 86(11):973-7. PubMed ID: 19213487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragile X expression in normal and mentally retarded subjects: effect of treatment with an antifolic agent.
    Sanfilippo S; Ragusa RM; Scillato F; Ruggeri M; Neri G
    Am J Med Genet; 1988; 30(1-2):369-76. PubMed ID: 3177459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetic investigations in mentally retarded and normal males from 14 families with the fragile site at Xq28. Results of folic acid treatment on fra(X) expression.
    Nielsen KB; Tommerup N
    Hum Genet; 1984; 66(2-3):225-9. PubMed ID: 6232199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three families with high expression of a fragile site at Xq27.3, lack of anomalies at the FMR-1 CpG island, and no clear phenotypic association.
    Oberlé I; Boué J; Croquette MF; Voelckel MA; Mattei MG; Mandel JL
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):224-31. PubMed ID: 1605195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autosomal folate sensitive fragile sites in normal and mentally retarded individuals in Greece.
    Mavrou A; Syrrou M; Tsenghi C; Metaxotou C
    Am J Med Genet; 1991; 38(2-3):437-9. PubMed ID: 2018086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of the fragile (X) syndrome in populations of mentally retarded individuals in Hawaii.
    Jacobs PA; Mayer M; Abruzzo MA
    Am J Med Genet; 1986; 23(1-2):567-72. PubMed ID: 3953666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening with the FMR1 protein test among mentally retarded males.
    de Vries BB; Mohkamsing S; van den Ouweland AM; Halley DJ; Niermeijer MF; Oostra BA; Willemsen R
    Hum Genet; 1998 Oct; 103(4):520-2. PubMed ID: 9856500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.